AVR compared with OKUR: revenue, margins and what each company keeps, and the suppliers and customers both name

AVRAnteris Technologies Global Corp.

Mkt capRevenueRevenue

OKUROnKure Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AVRAnteris Technologies Global Corp.

OKUROnKure Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AVR

0 of 2at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▼−3.27%—

May 13 '26±12.1%▼−2.54%×0.21

Q1 FY26±26.5%▲+2.68%×0.10

Q3 FY25—▼−2.57%—

OKUR1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±80.0%▲+1.46%×0.02

= impliedAVR realized, solidOKUR realized, hatchedOne scale, both sides: full bar = 80%× = |realized| ÷ impliedSource: market data

AVRAnteris Technologies Global Corp.

6.30▼−1.81%· post 6.30

Mkt cap$615.0MRevenue$1MQ2 FY26Revenue$2MFY25

OKUROnKure Therapeutics, Inc.

2.63▲+0.50%· post 2.63

ClosedOct 30 '26

Mkt cap$106.1MRevenue—Revenue—

Compare

ClosedOct 30 '26

AVRAnteris Technologies Global Corp.

OKUROnKure Therapeutics, Inc.

6.30▼−1.81%post 6.30

Price

2.63▲+0.50%post 2.63

$615.0M

Mkt cap

$106.1M

Q2 FY26$1M

Revenue

—

FY25$2M

Revenue

—

AVR6.30▼−1.81%vsOKUR2.63▲+0.50%ClosedOct 30 '26